Johnson & Johnson Innovation - JJDC’s Genocea Biosciences, Inc. GNCA Stock Holding History

Johnson & Johnson Innovation - JJDC’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-43,177	Closed	-$99K	–	17
2020 Q3	$99K	Sell	43,177 -100,787	-70%	-$264K	0.02%	16
2020 Q2	$331K	Hold	143,964	–	–	0.07%	13
2020 Q1	$248K	Hold	143,964	–	–	0.14%	11
2019 Q4	$298K	Buy	+143,964	New	+$342K	0.11%	10

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Johnson & Johnson Innovation - JJDC's GNCA Position: Q4 2020 in Review

Johnson & Johnson Innovation - JJDC sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 43,177 shares — an estimated $99K sold.

Johnson & Johnson Innovation - JJDC first reported a position in GNCA in Q4 2019 and held it in 4 quarters. The position peaked at $331K in Q2 2020. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

Johnson & Johnson Innovation - JJDC reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
Johnson & Johnson Innovation - JJDC sold 43,177 Genocea Biosciences, Inc. shares in Q4 2020, an estimated $99K.
Johnson & Johnson Innovation - JJDC first reported a position in Genocea Biosciences, Inc. in Q4 2019 and held it in 4 quarters.
Johnson & Johnson Innovation - JJDC's Genocea Biosciences, Inc. position peaked at $331K in Q2 2020.
39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on Johnson & Johnson Innovation - JJDC's 13F filing for Q4 2020, filed 9 Feb 2021.